Skip to main content
Equibles

MetLife Investment Management, LLC

Position in LRMR — Larimar Therapeutics, Inc.

CIK 1529735 Whippany, NJ
Back to LRMR Full portfolio

Position in LRMR

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$121,383
+$1,377 QoQ
Shares Held
39,798
+49.2% QoQ
Ownership
0.038%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#81
of 163 holders
Holding Since
Mar 2024
9 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in LRMR Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

MetLife Investment Management, LLC holds $433,929,439 across 249 Biotechnology names. LRMR ranks #227 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 HALO
Halozyme Therapeutics, Inc.
 402,605 $31,511,893
2 PRAX
Praxis Precision Medicines, Inc.
 90,543 $30,312,890
3 VRTX
Vertex Pharmaceuticals Inc / Ma
 58,072 $28,846,104
4 FTRE
Fortrea Holdings Inc.
 1,362,169 $23,701,740
5 AXSM
Axsome Therapeutics, Inc.
 89,662 $21,946,567
6 IMNM
Immunome Inc.
 859,076 $18,203,820
7 REGN
Regeneron Pharmaceuticals, Inc.
 22,880 $14,266,595
8 CYTK
Cytokinetics Inc
 140,046 $11,930,518

All Filings in LRMR

Export CSV
9 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $121,383 39,798
2026-03-31 $120,006 26,668
2025-12-31 $51,804 13,597
2025-09-30 $83,033 25,707
2025-06-30 $76,177 26,359
2024-12-31 $71,316 18,428
2024-09-30 $162,472 24,805
2024-06-30 $179,836 24,805
2024-03-31 $105,675 13,923